Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LOXO-260 |
Synonyms | |
Therapy Description |
LOXO-260 is a selective RET inhibitor with activity against RET solvent front and gatekeeper mutations and fusions, with potential anti-tumor activity (J of Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS8595). |